Atria Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.33M | Buy |
17,514
+833
| +5% | +$143K | 0.03% | 526 |
|
|
2026
Q1 | $2.82M | Buy |
16,681
+808
| +5% | +$138K | 0.03% | 549 |
|
|
2025
Q4 | $2.68M | Buy |
15,873
+14,316
| +919% | +$2.33M | 0.03% | 606 |
|
|
2025
Q3 | $225K | Sell |
1,557
-39
| -2% | -$5.32K | ﹤0.01% | 1883 |
|
|
2025
Q2 | $202K | Sell |
1,596
-664
| -29% | -$81.5K | ﹤0.01% | 1923 |
|
|
2025
Q1 | $289K | Buy |
2,260
+532
| +31% | +$72.1K | ﹤0.01% | 1637 |
|
|
2024
Q4 | $228K | Buy |
1,728
+28
| +2% | +$3.94K | ﹤0.01% | 1725 |
|
|
2024
Q3 | $248K | Sell |
1,700
-315
| -16% | -$45.6K | ﹤0.01% | 1716 |
|
|
2024
Q2 | $277K | Buy |
+2,015
| New | +$269K | ﹤0.01% | 1636 |
|
|
2020
Q3 | – | Sell |
-8,197
| Closed | -$1.12M | – | 590 |
|
|
2020
Q2 | $1.12M | Buy |
+8,197
| New | +$1.04M | 0.04% | 477 |
|
|
2020
Q1 | – | Sell |
-2,467
| Closed | -$297K | – | 831 |
|
|
2019
Q4 | $297K | Buy |
+2,467
| New | +$275K | 0.01% | 979 |
|
|
2018
Q4 | – | Sell |
-3,115
| Closed | -$380K | – | 940 |
|
|
2018
Q3 | $380K | Buy |
+3,115
| New | +$367K | 0.02% | 687 |
|
|
2018
Q1 | – | Sell |
-2,322
| Closed | -$248K | – | 888 |
|
|
2017
Q4 | $248K | Sell |
2,322
-4,173
| -64% | -$446K | 0.01% | 714 |
|
|
2017
Q3 | $722K | Buy |
+6,495
| New | +$694K | 0.04% | 380 |
|
|
2016
Q4 | – | Sell |
-6,768
| Closed | -$653K | – | 652 |
|
|
2016
Q3 | $653K | Buy |
+6,768
| New | +$644K | 0.06% | 268 |
|
|
2016
Q1 | – | Sell |
-8,085
| Closed | -$814K | – | 458 |
|
|
2015
Q4 | $814K | Buy |
8,085
+2,319
| +40% | +$252K | 0.09% | 171 |
|
|
2015
Q3 | $583K | Buy |
5,766
+666
| +13% | +$79.9K | 0.08% | 173 |
|
|
2015
Q2 | $627K | Sell |
5,100
-273
| -5% | -$32.7K | 0.07% | 200 |
|
|
2015
Q1 | $615K | Sell |
5,373
-156
| -3% | -$17.2K | 0.07% | 211 |
|
|
2014
Q4 | $559K | Buy |
5,529
+72
| +1% | +$7K | 0.06% | 235 |
|
|
2014
Q3 | $498K | Sell |
5,457
-1,560
| -22% | -$137K | 0.05% | 276 |
|
|
2014
Q2 | $601K | Sell |
7,017
-1,467
| -17% | -$116K | 0.06% | 249 |
|
|
2014
Q1 | $669K | Buy |
8,484
+1,266
| +18% | +$105K | 0.07% | 239 |
|
|
2013
Q4 | $546K | Buy |
7,218
+1,269
| +21% | +$90K | 0.05% | 276 |
|
|
2013
Q3 | $416K | Sell |
5,949
-9
| -0.2% | -$590 | 0.04% | 309 |
|
|
2013
Q2 | $345K | Buy |
+5,958
| New | +$344K | 0.04% | 259 |
|
Other funds holding IBB
CB
Atria Investments's IBB Position: Q2 2026 in Review
Atria Investments increased its iShares Biotechnology ETF (IBB) stake by 5% in Q2 2026, buying an estimated $143K and bringing the position to 17,514 shares worth $3.33M. The position accounts for 0.03% of the portfolio, ranked #526.
Atria Investments first reported a position in IBB in Q2 2013 and has held it in 26 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Atria Investments held 17,514 shares of iShares Biotechnology ETF worth $3.33M as of Q2 2026.
- Atria Investments bought 833 iShares Biotechnology ETF shares in Q2 2026, an estimated $143K.
- iShares Biotechnology ETF made up 0.03% of Atria Investments's portfolio in Q2 2026, its #526 holding.
- Atria Investments first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 26 quarters since.
- 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.